ID: ALA5279388

Max Phase: Preclinical

Molecular Formula: C13H12BrNO5S

Molecular Weight: 374.21

Associated Items:

Representations

Canonical SMILES:  COc1cc(Br)cc(CC2SC(=O)NC2=O)c1CC(=O)O

Standard InChI:  InChI=1S/C13H12BrNO5S/c1-20-9-4-7(14)2-6(8(9)5-11(16)17)3-10-12(18)15-13(19)21-10/h2,4,10H,3,5H2,1H3,(H,16,17)(H,15,18,19)

Standard InChI Key:  ODKDXGPZDQVEDN-UHFFFAOYSA-N

Associated Targets(Human)

Peroxisome proliferator-activated receptor gamma 15191 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 374.21Molecular Weight (Monoisotopic): 372.9620AlogP: 1.98#Rotatable Bonds: 5
Polar Surface Area: 92.70Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.09CX Basic pKa: CX LogP: 2.20CX LogD: -1.97
Aromatic Rings: 1Heavy Atoms: 21QED Weighted: 0.82Np Likeness Score: 0.08

References

1. Naim MJ, Alam MJ, Ahmad S, Nawaz F, Shrivastava N, Sahu M, Alam O..  (2017)  Therapeutic journey of 2,4-thiazolidinediones as a versatile scaffold: An insight into structure activity relationship.,  129  [PMID:28231521] [10.1016/j.ejmech.2017.02.031]

Source